Erythropoiesis-stimulating agents for myelodysplastic syndromes

  • Protocol
  • Intervention

Authors

  • Andrés M Acevedo,

    Corresponding author
    1. Fundación Santa Fe de Bogotá, Hematology and Bone Marrow Transplantation Department, Bogotá, Cundinamarca, Colombia
    • Andrés M Acevedo, Hematology and Bone Marrow Transplantation Department, Fundación Santa Fe de Bogotá, Calle 119 No. 7-75, Instituto de Oncología Carlos Ardila Lulle, Bogotá, Cundinamarca, 110111, Colombia. andres_acevedo@hotmail.com.

    Search for more papers by this author
  • Myriam Lucía Rodríguez,

    1. Fundación Santa Fe de Bogotá, Hematology and Bone Marrow Transplantation Department, Bogotá, Cundinamarca, Colombia
    Search for more papers by this author
  • Henry A Becerra,

    1. Fundación Santa Fe de Bogotá, Clinical and Translational Oncology Group, Institute of Oncology, Bogotá, Colombia
    Search for more papers by this author
  • Andrés Felipe Cardona,

    1. Institute of Oncology, Fundación Santa Fe de Bogotá, Clinical and Translational Oncology Group, Bogotá, Cundinamarca, Colombia
    Search for more papers by this author
  • Arturo J Martí-Carvajal

    1. Universidad Tecnológica Equinoccial, Facultad de Ciencias de la Salud Eugenio Espejo, Quito, Ecuador
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the clinical efficacy and safety of using any ESA for the treatment of anemia related to MDS in adult patients in terms of overall survival, quality of life, hematologic response and transfusional requirement?